Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound chamomile lidocaine gel for postoperative pain after septoplasty
ChiCTR2600124582Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine in deviated nasal septum (DNS) (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Nasal pain VAS score at 6 hours postoperatively. Planned start May 2026; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
deviated nasal septum (DNS)
Beyond the preview
Go deeper on ChiCTR2600124582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124582.